We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
COPD – eine unterschätzte Erkrankung.
- Authors
Leuppi, Jörg D.; Bridevaux, Pierre-Olivier; Charbonnier, Florian; Clarenbach, Christian F.; Duchna, Hans-Werner; Fellrath, Jean-Marc; Gianella, Pietro; Jochmann, Anja; Kern, Lukas; Pavlov, Nikolay; Rothe, Thomas; Steurer-Stey, Claudia; von Garnier, Christophe
- Abstract
Abstract: Chronic obstructive pulmonary disease (COPD) is a heterogeneous lung condition with a complex clinical picture. The diagnosis is not easy to make because COPD can develop insidiously and remain unnoticed for a long time. Therefore, general practitioners play a central role in the early detection of the disease. Suspected COPD can be confirmed by special examinations in collaboration with pulmonologists. The new GOLD guideline defines three COPD risk groups (A-B-E) which should guide the personalized treatment concept. A short- or long-acting bronchodilator (SAMA/SABA or LAMA/LABA) is recommended for group A, and a dual long-acting bronchodilator therapy (LABA+LAMA) is recommended for group B and E. In case of blood eosinophilia (≥300 cells/µl) and/or recent hospitalization for COPD exacerbation, triple therapy (LABA+LAMA+ICS) is recommended. General practitioners are important in implementing non-pharmacological measures (smoking cessation, regular exercise, vaccinations, patient selfmanagement education). However, this also underlines the high demands of the implementation of the GOLD guideline in daily practice.
- Subjects
SABA (Netherlands); GENERAL practitioners; CHRONIC obstructive pulmonary disease; EARLY diagnosis; GOLD; SMOKING cessation; PATIENT education
- Publication
Praxis (16618157), 2023, Vol 112, Issue 7/8, p403
- ISSN
1661-8157
- Publication type
Article
- DOI
10.1024/1661-8157/a004049